1. Joseph P, Leong D, McKee M, Anand SS, Schwalm JD, Teo K, Mente A, Yusuf S. Reducing the global burden of cardiovascular disease, part 1: the epidemiology and risk factors. Circ Res 2017;121:677-694.
4. Gordon DJ, Probstfield JL, Garrison RJ, Neaton JD, Castelli WP, Knoke JD, Jacobs DR Jr, Bangdiwala S, Tyroler HA. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation 1989;79:8-15.
5. Ford ES, Ajani UA, Croft JB, Critchley JA, Labarthe DR, Kottke TE, Giles WH, Capewell S. Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. N Engl J Med 2007;356:2388-2398.
6. Elkins C, Fruh S, Jones L, Bydalek K. Clinical practice recommendations for pediatric dyslipidemia. J Pediatr Health Care 2019;33:494-504.
7. Ha KH, Kwon HS, Kim DJ. Epidemiologic characteristics of dyslipidemia in Korea. J Lipid Atheroscler 2015;4:93-99.
9. Steinberger J, Daniels SR, Hagberg N, Isasi CR, Kelly AS, Lloyd-Jones D, Pate RR, Pratt C, Shay CM, Towbin JA, Urbina E, Van Horn LV, Zachariah JP; American Heart Association Atherosclerosis, Hypertension, and Obesity in the Young Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; Council on Epidemiology and Prevention; Council on Functional Genomics and Translational Biology; and Stroke Council. Cardiovascular Health Promotion in Children: challenges and opportunities for 2020 and beyond: a scientific statement from the American Heart Association. Circulation 2016;134:e236-e255.
10. Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents; National Heart, Lung, and Blood Institute. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics 2011;128 Suppl 5:S213-S256.
11. Lim JS, Kim EY, Kim JH, Yoo JH, Yi KH, Chae HW, Choi JH, Kim JY, Hwang IT; Committee of Dyslipidemia of Korean Children and Adolescents on behalf of Korean Society of Pediatric Endocrinology (KSPE). 2017 Clinical practice guidelines for dyslipidemia of Korean children and adolescents. Ann Pediatr Endocrinol Metab 2020;25:199-207.
12. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults. Lancet 2017;390:2627-2642.
14. Choi S, Kim Y, Park S, Lee J, Oh K. Trends in cigarette smoking among adolescents and adults in South Korea. Epidemiol Health 2014;36:e2014023.
15. Kim HJ, Oh SY, Lee DW, Kwon J, Park EC. The effects of intense physical activity on stress in adolescents: findings from Korea Youth Risk Behavior Web-Based Survey (2015-2017). Int J Environ Res Public Health 2019;16:1870.
17. Dathan-Stumpf A, Vogel M, Hiemisch A, Thiery J, Burkhardt R, Kratzsch J, Kiess W. Pediatric reference data of serum lipids and prevalence of dyslipidemia: results from a population-based cohort in Germany. Clin Biochem 2016;49:740-749.
20. Ding W, Cheng H, Yan Y, Zhao X, Chen F, Huang G, Hou D, Mi J. 10-year trends in serum lipid levels and dyslipidemia among children and adolescents from several schools in Beijing, China. J Epidemiol 2016;26:637-645.
21. Ding W, Dong H, Mi J. Prevalence of dyslipidemia in Chinese children and adolescents:a meta-analysis. Zhonghua Liu Xing Bing Xue Za Zhi 2015;36:71-77.
22. Taheri F, Chahkandi T, Kazemi T, Bijari B, Zardast M, Namakin K. Lipid profiles and prevalence of dyslipidemia in Eastern Iranian adolescents, Birjand, 2012. Iran J Med Sci 2015;40:341-348.
23. Yang S, Hwang JS, Park HK, Lee HS, Kim HS, Kim EY, Lim JS. Serum lipid concentrations, prevalence of dyslipidemia, and percentage eligible for pharmacological treatment of Korean children and adolescents; data from the Korea National Health and Nutrition Examination Survey IV (2007-2009). PLoS One 2012;7:e49253.
24. Hickman TB, Briefel RR, Carroll MD, Rifkind BM, Cleeman JI, Maurer KR, Johnson CL. Distributions and trends of serum lipid levels among United States children and adolescents ages 4-19 years: data from the Third National Health and Nutrition Examination Survey. Prev Med 1998;27:879-890.
25. Ford ES, Li C, Zhao G, Mokdad AH. Concentrations of low-density lipoprotein cholesterol and total cholesterol among children and adolescents in the United States. Circulation 2009;119:1108-1115.
26. Kim SH, Ahn BC, Joung H, Park MJ. Lipid profiles and prevalence of dyslipidemia in Korean adolescents. Endocrinol Metab 2012;27:208-216.
30. Song K, Park G, Lee HS, Choi Y, Oh JS, Choi HS, Suh J, Kwon A, Kim HS, Chae HW. Prediction of insulin resistance by modified triglyceride glucose indices in youth. Life (Basel) 2021;11:286.
33. Song K, Park G, Choi Y, Oh JS, Choi HS, Suh J, Kwon A, Kim HS, Chae HW. Association of vitamin D status and physical activity with lipid profile in Korean children and adolescents: a population-based study. Children (Basel) 2020;7:241.
35. Manlhiot C, Larsson P, Gurofsky RC, Smith RW, Fillingham C, Clarizia NA, Chahal N, Clarke JT, McCrindle BW. Spectrum and management of hypertriglyceridemia among children in clinical practice. Pediatrics 2009;123:458-465.
36. Tonstad S, Knudtzon J, Sivertsen M, Refsum H, Ose L. Efficacy and safety of cholestyramine therapy in peripubertal and prepubertal children with familial hypercholesterolemia. J Pediatr 1996;129:42-49.